Alopecia

Showing 26 - 50 of 77

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Platelet-Rich Plasma Versus Mesotherapy in Androgenetic

Not yet recruiting
  • Androgenetic Alopecia
  • +2 more
  • Platelet-rich plasma
  • Mesotherapy
  • (no location specified)
Nov 11, 2021

Breast Cancer, Alopecia Trial in United States (PAXMAN Orbis Scalp Cooler, Control No treatment)

Active, not recruiting
  • Breast Cancer
  • Alopecia
  • PAXMAN Orbis Scalp Cooler
  • Control No treatment
  • Morristown, New Jersey
  • +6 more
Jul 25, 2021

Alopecia Trial in Lviv (1565nm non ablative fractional laser)

Active, not recruiting
  • Alopecia
  • 1565nm non ablative fractional laser
  • Lviv, Ukraine
    AMG
Jul 6, 2021

Alopecia Trial in Irvine (Fraxel Dual laser, Halo laser)

Active, not recruiting
  • Alopecia
  • Fraxel Dual laser
  • Halo laser
  • Irvine, California
    University of California, Irvine, Department of Dermatology, Der
Jun 2, 2021

Alopecia Trial in Mendham, Great Neck (LLLT)

Completed
  • Alopecia
  • LLLT
  • Mendham, New Jersey
  • +1 more
May 18, 2021

COVID-19 Induced Telogen Effluvium

Recruiting
  • Covid19
  • +3 more
  • Blood Tests
  • Istanbul, Kadıköy, Turkey
    Istanbul Medeniyet University
Apr 4, 2021

Patients With Different Types of Alopecia

Completed
  • Alopecia
  • Quality of Life
  • general quality of life questionary
  • specific quality of life questionary
  • Amiens, France
    CHU Amiens
Dec 1, 2020

Female Pattern Baldness, Hair Loss, Alopecia Trial in Taipei (ENERGI-F701, Regaine)

Completed
  • Female Pattern Baldness
  • +2 more
  • Taipei, Taiwan
    Taipei Veterans General Hospital
Nov 23, 2020

Androgenetic Alopecia, Alopecia Trial in New York (Platelet Rich Plasma, Normal saline)

Completed
  • Androgenetic Alopecia
  • Alopecia
  • Platelet Rich Plasma
  • Normal saline
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Oct 8, 2020

Alopecia Trial in London (Integrative Cognitive Behavioural Therapy)

Completed
  • Alopecia
  • Integrative Cognitive Behavioural Therapy
  • London, United Kingdom
    Royal Free Hospital
Sep 21, 2020

Alopecia Trial in United States (ATI-501 400mg BID (Low dose), ATI-501 600mg BID (Mid dose), ATI-501 800mg BID (High dose))

Completed
  • Alopecia
  • ATI-501 400mg BID (Low dose)
  • +3 more
  • Hot Springs, Arkansas
  • +24 more
Aug 27, 2020

Alopecia, Breast Cancer Trial in Los Angeles (bimatoprost ophthalmic solution, )

Withdrawn
  • Alopecia
  • Breast Cancer
  • bimatoprost ophthalmic solution
  • placebo
  • Los Angeles, California
    University of California Los Angeles
Jul 29, 2020

Alopecia Trial in Jacksonville (Platelet Rich Plasma, Minoxidil Foam)

Completed
  • Alopecia
  • Platelet Rich Plasma
  • Minoxidil Foam
  • Jacksonville, Florida
    Mayo Clinic Florida
Apr 6, 2020

Alopecia Trial in Lausanne (CG 428 cutaneous solution, Placebo cutaneous solution)

Completed
  • Alopecia
  • CG 428 cutaneous solution
  • Placebo cutaneous solution
  • Lausanne, Switzerland
    CHUV Lausanne
Aug 12, 2019

Alopecia Trial in United States (Setipiprant, Placebo, Finasteride)

Completed
  • Alopecia
  • Hot Springs, Arkansas
  • +17 more
Mar 15, 2019

Alopecia Trial in San Diego (Hair Stimulating Complex (HSC), Phosphate Buffered Saline)

Unknown status
  • Alopecia
  • Hair Stimulating Complex (HSC)
  • Phosphate Buffered Saline
  • San Diego, California
    Cosmetic Laser Dermatology
Feb 20, 2019

Alopecia Trial in Worldwide (Dutasteride, Placebo)

Completed
  • Alopecia
  • Santiago, Región Metro De Santiago, Chile
  • +17 more
Sep 11, 2018

Testing in Females With Female Pattern Hair Loss

Completed
  • Alopecia
  • Female Pattern Hair Loss
  • 5% minoxidil topical foam
  • Tucson, Arizona
  • +4 more
Oct 4, 2018

Alopecia Trial in Seoul (CG428, Placebo)

Completed
  • Alopecia
  • CG428
  • Placebo
  • Seoul, Korea, Republic of
    Danbee Kang
Aug 30, 2018

Alopecia, Chemo Effects Trial in Seoul (CG428)

Completed
  • Alopecia
  • Chemotherapy Effects
  • CG428
  • Seoul, Korea, Republic of
    Danbee Kang
Aug 30, 2018

Alopecia Trial (Dutasteride 0.5mg oral tablets)

Completed
  • Alopecia
  • Dutasteride 0.5mg oral tablets
  • (no location specified)
Jul 20, 2018

Alopecia Trial in Fukuoka, Osaka, Tokyo (Dutasteride 0.5 mg)

Completed
  • Alopecia
  • Dutasteride 0.5 mg
  • Fukuoka, Japan
  • +4 more
Jun 18, 2018

AVODART® Alopecia Post-marketing Surveillance (PMS)

Completed
  • Alopecia
  • Daejeon, Korea, Republic of
    GSK Investigational Site
Jun 18, 2018

Alopecia Trial in Randwick (GI198745 0.1 mg, GI198745 0.5 mg)

Completed
  • Alopecia
  • GI198745 0.1 mg
  • GI198745 0.5 mg
  • Randwick, New South Wales, Australia
    GSK Investigational Site
Jun 18, 2018

Hair Loss/Baldness, Alopecia Trial in Beirut (Lipoaspiration, Transplantation)

Unknown status
  • Hair Loss/Baldness
  • Alopecia
  • Lipoaspiration
  • Transplantation
  • Beirut, Lebanon
    Lebanese University, faculty of Sciences, section II and III
Feb 22, 2018